武清前列腺治疗医院武清区龙济医院天津龙济医院泌尿医院服务如何,天津市龙济包皮环切价格,天津市龙济医院男性专科医院好不好,天津市武清区龙济男科行不行,武清区龙济泌尿专科医院路线,天津市武清区龙济泌尿专科医院偏热,治疗早射优武清区龙济医院

JAKARTA, Sept. 21 (Xinhua) -- Comprehensive efforts are needed to save coral reefs as their living compound is prone to environmental damage, an Indonesian expert told Xinhua in an exclusive interview on Tuesday.Nurul Dhewani Mirah Sjafrie, coordinator of Coral Reef Information and Training Center (CRITC) for western Indonesia at the Indonesian Science Institute, the government think-tank institution, said that currently only more than five percent of coral reefs in Indonesia are in "excellent condition.""Based on monitoring of the thousands of observation stations we have, the rest are in damage, bad and moderate condition," Sjafrie said in her office.She said that it is not impossible to increase the number as long as all people are aware of the importance to save coral reefs."People should be aware that coral reefs live in sea with warm enough temperature of 18-25 Celsius degree with certain level of brightness, among others. If the requirements are fulfilled, we can see coral reef growing safely," said Sjafrie.She also said it needs upstream-to-downstream arrangement to support the efforts."For example, in western Indonesia, we have many big rivers. If illegal logging practice keeps continuing, it will cause sedimentation in the sea. It means there is a decreasing quality. So, coral reef salvation is not only conducted in ocean," Sjafrie said.She also expressed concern that many people dump garbage in rivers."They throw their garbage in plastic bags. For plastic only, it takes 100 years to be completely decomposed. Let's say 10-15 percent of our people do the malpractice everyday, you can imagine how many garbage entering the sea," she said.Sjafrie said that the key to guard coral reef sustainability is in human habit."Coral reef destruction could be caused by nature such as tsunami, earthquake, crown torn (Acanthaster plancii) that consumes coral reefs. But the biggest factor is human with their destructive fishing using bombs," she said.According to Sjafrie, people do the practice with three causes, namely ignorance, needs and greed.She added that efforts have been conducted by the government, private sector and non governmental organizations (NGOs) to save coral reefs."We have a program called the CORMAP of Coral Reef Rehabilitation and Management Program. The government uses instrument of National Program of People Empowerment while NGOs do their part. If we could combine the actions, we could reach the same goal," she said.She added that the government train people to be productive by providing skills and in the same time, her organization and NGOs socialize and campaign the importance of coral reefs."When people have better jobs and activities and they are equipped with the awareness, they will do positive thing and stop destroying the sea," Sjafrie said.

SYDNEY, Sept. 5 (Xinhua) -- Australian scientists believe " brown fat," a wondrous tissue that burns energy to generate heat, could help people fight obesity, local media reported on Monday.A research team from Sydney's Garvan Institute of Medical Research (GIMR) has worked out how to grow brown fat from stem cells biopsied from adults, raising hopes that one day brown fat could be transplanted in obese people to speed up calories they burn, the Australian Associated Press (AAP) reported.Garvan endocrinologist Paul Lee, who led the research, is optimistic about targeting brown fat as an obesity intervention, commenting "it's a highly metabolically active form of fat, and very exciting that we may be able to stimulate its growth in people."People are born with supplies of brown fat around their neckline to keep them warm as infants, according to scientists at GIMR.Scientists now know that brown fat is present in most, if not all, adults mainly just behind the collarbone.Studies have found that adults with brown fat are slimmer than those without."Although this is early work, it is a proof of concept study showing that the growth of brown fat cells is possible, using precursor cells taken from adult humans, under appropriate stimulation," Lee said."Regardless of whether or not someone has lots of or little brown fat, the precursor cells are universally present. Under the appropriate growth factor and hormonal stimulation, the cells all grow and differentiate into mature brown fat cells."However, Lee warned more work was needed.Lee said even if brown fat was transplanted into obese people or drugs developed to stimulate the growth of brown fat, exercise and a healthy diet would still be crucial to aiding weight loss."So I don't think this is a solution to obesity because there are so many other factors (involved in obesity)," he said."Despite how efficient brown fat is at burning energy, we would only need a few doughnuts to diminish or negate its benefits."Lee said it would be years before tests could be carried out on brown fat transplants.In the meantime, he is expanding his study to test different ways to grow brown fat.His study, to be printed in the October issue of Endocrinology, has been published in the online edition of the journal.

LOS ANGELES, June 5 (Xinhua) -- U.S. researchers have developed two new drugs that can prolong the lives of patients with advanced melanoma, it was announced on Sunday.Research on both drugs was presented at the on-going annual meeting of the American Society of Clinical Oncology in Chicago, according to HealthDay News.This is the first big news in years for treatment of melanoma, one of the deadliest forms of skin cancer and one that is notoriously difficult to treat, let alone cure, the report said.The first treatment, vemurafenib, inhibits a gene mutation harbored in half of all melanoma patients, but is not yet approved by the U.S. Food and Drug Administration.The other drug, Yervoy (ipilumumab), is an immune system therapy that won approval in March."The March FDA approval of ipilumumab (Yervoy) was the first new drug approval for melanoma in 13 years," said Tim Turnham, executive director of the Melanoma Research Foundation.The two drugs were developed by researchers at Memorial Sloan- Kettering Cancer Center in New York City, the report said."This is really a huge step toward personalized care in melanoma," Dr. Paul Chapman, lead author of the first study and the attending physician in the melanoma/sarcoma service at Memorial Sloan-Kettering, said in a statement. "This (vemurafenib) is the first successful melanoma treatment tailored to patients who carry a specific gene mutation in their tumor, and could eventually become one of only two drugs available that improves overall survival in advanced cancers.""Having two trials that show a benefit in survival in patients with melanoma, both of these in first-line settings -- we weren't here just a few years ago," said Dr. Stephen Hodi, director of the Melanoma Center at Dana Farber Cancer Institute in Boston. "These are huge, paradigm-shifting results for the field."In the vemurafenib trial, sponsored by the drug's makers, researchers randomly assigned 675 patients with advanced, inoperable melanoma to receive either the chemotherapy drug dacarbazine or vemurafenib. Vemurafenib targets the V600E mutation in the BRAF gene.At the three-month mark, patients taking vemurafenib were 63 percent less likely to die and 74 percent less likely to die or see their cancer return, compared to patients taking dacarbazine alone.Few patients had side effects in the vemurafenib group, although some did develop squamous cell carcinoma, a less dangerous form of skin cancer.This is the first drug that has been proven superior to chemotherapy in this group of hard-to-treat patients, the researchers said."There was such a substantial benefit that we recommended that patients cross over," Chapman said at a Sunday news briefing. "It' s unprecedented to report a trial this early. The median follow-up time was three months." Yet the differences between the two groups became evident almost immediately.Dr. Lynn Schuchter, co-moderator of the briefing and division chief of hematology-oncology at Abramson Cancer Center of the University of Pennsylvania in Philadelphia, said symptoms subsided in some patients almost immediately, enabling them to cut back on pain medication in just 72 hours."The median time to progression with dacarbazine was 1.6 months versus three months with vemurafenib, which is a huge difference," said Chapman.In the second study, about 500 patients were randomly picked to receive Yervoy plus dacarbazine or dacarbazine alone.Those taking both drugs lived a median of 11.2 months compared to 9.1 months for those taking dacarbazine alone. Time to recurrence of disease was about the same for both groups: 2.8 months and 2.6 months, respectively.Almost half of those taking the combination therapy were alive after one year, compared to 36.3 percent in the other group. After two years, the rates were 28.5 percent and 17.9 percent, respectively.By three years out, 20.8 percent of those in the combination group were alive compared with 12.2 percent of those taking chemotherapy alone.This is the first study to combine chemotherapy and immunotherapy both safely and effectively.A study to test vemurafenib in combination with Yervoy has already begun, according to HealthDay News.

Robots perform a dance in a competition in Mudanjiang, northeast China's Heilongjiang Province, July 24, 2011. A nationwide robot competition was kicked off in the city on Sunday, with participants from 50 colleges and universities

BEIJING, Sept. 23 (Xinhua) -- A defunct U.S. satellite is expected to crash down to Earth Friday, with nobody knowing where or when exactly it will hit. This was avoidable, a Chinese expert said Thursday.Pang Zhihao, a researcher from the Chinese Research Institute of Space Technology, told Xinhua that the crash could have been avoided had the satellite been put into a higher orbit, or manipulated to drop in the South Pacific when it had abundant fuel. It would pose no threat to Earth if these measures had been taken.NASA's tumbling, 5,900 kg Upper Atmosphere Research Satellite, or UARS, is the first of such man-made space vehicles that have been launched into outer space according to the agency's Mission to Planet Earth. The mission was launched in the 1990s.The mission is designed to provide data for better understanding Earth's upper atmosphere and the effects of natural and human interactions on the atmosphere.The satellite was deactivated in 2005 as it ran out of fuel and was left orbiting Earth like a big piece of space junk.There are other cases of defunct satellites. The European Space Agency said earlier its observation satellite ERS-2 has run out of fuel and is deorbiting. It would therefore also crash sooner or later.Pang said all countries which are operating space vehicles should take care of their own spacecrafts so that they won't pose any danger.The expert also said that the public need not worry too much.Pang said most spacecrafts will be incinerated upon re-entering Earth's atmosphere, and the debris will mostly likely fall into the ocean or hit an uninhabited area. In addition, a debris tracker is able to give a comparatively accurate prediction where the craft will fall about two hours before it hits Earth, giving residents, if there are any, time to evacuate.He added that there are several ways to minimize the threat of decommissioned spacecrafts, like putting them into higher orbits and crashing them into designated waters.Scientific progress would possibly bring about more ways of dealing with tumbling satellites. Scientists have already been trying to build spacecrafts with degradable materials so that they can self-destruct when re-entering Earth's atmosphere.